Lymphatic Radiobiology
淋巴放射生物学
基本信息
- 批准号:8326221
- 负责人:
- 金额:$ 23.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-12 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirus VectorAdenovirusesAdvocateAffectAftercareAnimal ModelAnimalsApoptoticAreaAwardAxillaAxillary Lymph Node DissectionBiochemistryBiological AssayBloodCaliberCancer PatientCell DeathCell ProliferationCell divisionCellsCessation of lifeCommitComplementComplicationDataDermalDevelopmentDoseEarEndothelial CellsEngineeringEquipmentExposure toFailureFibroblast Growth Factor 2FutureGeneral HospitalsGoalsGrowthGrowth FactorGrowth Factor ReceptorsHumanImageImaging technologyImmunohistochemistryIn VitroIncidenceIncubatedInfectionIonizing radiationK-Series Research Career ProgramsKineticsLaboratoriesLeadLightLymphangiogenesisLymphangiographyLymphaticLymphatic Endothelial CellsLymphatic vesselLymphedemaMalignant NeoplasmsMeasuresMediatingMentorsMentorshipMethodsMitosisMitoticMolecularMolecular BiologyMolecular TargetMonitorMusNatureNecrosisNeuropilin-1Neuropilin-2Operative Surgical ProceduresPainPathway interactionsPatientsPhasePre-Clinical ModelPreventionPrior TherapyProliferatingRadiationRadiation ToleranceRadiation induced damageRadiation therapyRadiation-Sensitizing AgentsRadiobiologyRelative (related person)ResearchResearch PersonnelResearch TrainingRiskSeedsSignal PathwaySignal TransductionSignaling MoleculeStaining methodStainsSwellingTechniquesTestingTherapeuticTissuesTrainingUnited StatesVascular Endothelial CellVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3VenousWomanWorkcancer cellcareerdesignexperiencefibroblast growth factor receptor 3genetic manipulationin vitro Modelin vivoinhibitor/antagonistintravital microscopyirradiationknowledge baselymph flowmalignant breast neoplasmnovelpreventradiation effectrepairedresearch studyresponsesenescenceskillssmall hairpin RNAsuccesstime usetooltreatment planning
项目摘要
Axillary radiation with surgery in breast cancer patients often leads to lymphedema, which affects nearly
400,000 women in the United States. Lymphedema is disfiguring, painful and forms a nidus for infection. As
current treatments provide little relief for many patients, it is critical to develop methods to prevent and
reverse the formation of lymphedema. The use of lymphangiogenic growth factors to spur lymphatic growth
and reverse lymphedema has been advocated. However, in cancer patients this strategy may facilitate the
further spread of cancer cells. To avoid this complication, we focus on lymphedema prevention in this
Pathway to Independence Award.
While information on the radiosensitivity of many tissues Is available, the effects of radiation on lymphatic
vessels have been largely unreported. In this proposal we will study the radiosensitivity of lymphatic
endothelial cells and their cellular and molecular response to radiation. We will then alter lymphatic
endothelial cell radiosensitivity through exposure to growth factors or genetic manipulation of growth factor
signaling. We will complement these studies by measuring the radiosensitivity of normal and proliferating
lymphatic vessels In vivo. Finally, we will prevent radiation-induced damage of lymphangiogenic vessels by
administering inhibitors of lymphatic growth factor receptors. The ultimate goal of this project is to identify
strategies to protect lymphatic vessels from radiation-induced damage in order to prevent lymphedema in
patients.
I will complete this worl< in the E.L. Steele Laboratories at IVIassachusetts General Hospital, which has the
approriate animal faciiities and intravital Imaging equipment necessary for the proposed experlmeints. My
mentors, Drs. Brian Seed and Kathryn Held, will continue to collaborate with me on this project and are
committed to the development of my career and will help my transition into a successful independent
academic researcher.
乳腺癌患者腋窝放射手术常导致淋巴水肿,其影响近
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY P PADERA其他文献
TIMOTHY P PADERA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY P PADERA', 18)}}的其他基金
Targeting lymph node metastases to block cancer progression
针对淋巴结转移阻止癌症进展
- 批准号:
10743193 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别:
Reversing aging-induced lymphatic dysfunction to improve immune function
逆转衰老引起的淋巴功能障碍,改善免疫功能
- 批准号:
10371505 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
Reversing aging-induced lymphatic dysfunction to improve immune function
逆转衰老引起的淋巴功能障碍,改善免疫功能
- 批准号:
10544735 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移预防癌症进展
- 批准号:
9286149 - 财政年份:2017
- 资助金额:
$ 23.75万 - 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移以预防癌症进展
- 批准号:
10542290 - 财政年份:2017
- 资助金额:
$ 23.75万 - 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
- 批准号:
8422972 - 财政年份:2012
- 资助金额:
$ 23.75万 - 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
- 批准号:
8225628 - 财政年份:2012
- 资助金额:
$ 23.75万 - 项目类别:
Characterizing lymphatic micrometastases: prognostic and therapeutic implications
淋巴微转移的特征:预后和治疗意义
- 批准号:
8146385 - 财政年份:2011
- 资助金额:
$ 23.75万 - 项目类别:
相似海外基金
Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
- 批准号:
19K09482 - 财政年份:2019
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
- 批准号:
2273599 - 财政年份:2019
- 资助金额:
$ 23.75万 - 项目类别:
Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
- 批准号:
18K14964 - 财政年份:2018
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
- 批准号:
16K18873 - 财政年份:2016
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
- 批准号:
9193681 - 财政年份:2016
- 资助金额:
$ 23.75万 - 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
- 批准号:
15K18939 - 财政年份:2015
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
- 批准号:
26450450 - 财政年份:2014
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
- 批准号:
26462183 - 财政年份:2014
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
- 批准号:
26893253 - 财政年份:2014
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
- 批准号:
24701021 - 财政年份:2012
- 资助金额:
$ 23.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




